Discounted Cash Flow Rating
Neutral
Return on Equity Rating
Sell
Debt to Equity Rating
Buy
Price to Earnings Rating
Sell
Analyst Rating
Neutral
Simple Moving Average
Strong Buy
Exponential Moving Average
Strong Buy
Relative Strength Index
Buy
Standard Deviation
Strong Buy
Williams %R
Strong Buy
Average Directional Index
Buy
Insider Trading
Buy
Wall Street Data Solutions Rating
Buy
A
GeneDx Holdings Corp. Class A Common Stock (WGS)
Services-health Services
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets. It has two segments GeneDx and Legacy Sema4 diagnostics.
333 LUDLOW STREET, NORTH TOWER, 8TH FLOOR
STAMFORD, CT
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
07/23/2021
Market Cap
915,416,562
Shares Outstanding
25,880,000
Weighted SO
25,884,279
Total Employees
N/A
Upcoming Earnings
07/30/2024
Similar Tickers
Beta
2.3620
Last Div
0.0000
Range
1.16-37.45
Chg
1.0950
Avg Vol
417674
Mkt Cap
915416562
Exch
NASDAQ
Country
US
Phone
800 298 6470
DCF Diff
N/A
DCF
0.0000
Div Yield
0.0000
P/S
3.7570
EV Multiple
-20.6779
P/FV
4.6619
Div Yield %
0.0000
P/E
-7.7007
PEG
-4.6284
Payout
0.0000
Current Ratio
2.3754
Quick Ratio
2.2242
Cash Ratio
0.8214
DSO
39.2373
DIO
31.0591
Op Cycle
70.2964
DPO
24.4754
CCC
45.8210
Gross Margin
0.5022
Op Margin
-0.3684
Pretax Margin
-0.4856
Net Margin
-0.4821
Eff Tax Rate
0.0072
ROA
-0.3019
ROE
-0.5318
ROCE
-0.2798
NI/EBT
0.9928
EBT/EBIT
1.3180
EBIT/Rev
-0.3684
Debt Ratio
0.1472
D/E
0.2951
LT Debt/Cap
0.2119
Total Debt/Cap
0.2279
Int Coverage
-131.8267
CF/Debt
-1.6024
Equity Multi
2.0052
Rec Turnover
9.3024
Pay Turnover
14.9130
Inv Turnover
11.7518
FA Turnover
4.2775
Asset Turnover
0.6262
OCF/Share
-3.4471
FCF/Share
-3.6080
Cash/Share
4.0146
OCF/Sales
-0.3766
FCF/OCF
1.0467
CF Coverage
-1.6024
ST Coverage
-17.9875
CapEx Coverage
-21.4228
Div&CapEx Cov
-21.4228
P/BV
4.6619
P/B
4.6619
P/S
3.7570
P/E
-7.7007
P/FCF
-9.5319
P/OCF
-9.8591
P/CF
-9.8591
PEG
-4.6284
P/S
3.7570
EV Multiple
-20.6779
P/FV
4.6619
DPS
0.0000
Latest Headlines (EST)
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
441.21K Shares Bought (85.11 %)
77.16K Shares Sold (14.89%)
3 - 6 Months
153.13K Shares Bought (45.09 %)
186.47K Shares Sold (54.91%)
6 - 9 Months
1.26M Shares Bought (52.26 %)
1.15M Shares Sold (47.74%)
9 - 12 Months
6.55K Shares Bought (50.00 %)
6.55K Shares Sold (50.00 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2020 | 2022 | 2022 | 2023 | 2024 | 1970 | 1970 | |
---|---|---|---|---|---|---|---|
Revenue | 63.96M | ▼ 57.80M | ▲ 61.35M | ▼ 57.42M | ▲ 62.42M | ▼ | |
Cost Of Revenue | 63.54M | ▼ 60.61M | ▲ 77.68M | ▼ 31.84M | ▼ 29.44M | ▼ | |
Gross Profit | 415.00K | ▼ -2.81M | ▼ -16.33M | ▲ 25.58M | ▲ 32.98M | ▼ | |
Gross Profit Ratio | 0.01 | ▼ -0.05 | ▼ -0.27 | ▲ 0.45 | ▲ 0.53 | ▼ | |
Research And Development Expenses | 31.16M | ▼ 22.25M | ▲ 24.37M | ▼ 10.03M | ▲ 11.37M | ▼ | |
General And Administrative Expenses | 61.12M | ▼ 57.96M | ▼ 40.65M | ▼ 26.63M | ▼ 22.45M | ▼ | |
Selling And Marketing Expenses | 30.03M | ▲ 30.65M | ▲ 31.80M | ▼ 15.56M | ▲ 16.09M | ▼ | |
Selling General And Administrative Expenses | 91.14M | ▼ 88.60M | ▼ 72.45M | ▼ 37.24M | ▼ 33.45M | ▼ | |
Other Expenses | -23.00K | ▲ 75.60M | ▼ 1.60M | ▼ -1.96M | ▲ -974.00K | ▼ | |
Operating Expenses | 125.46M | ▼ 112.97M | ▼ 98.41M | ▼ 49.23M | ▼ 45.80M | ▼ | |
Cost And Expenses | 189.00M | ▼ 173.58M | ▲ 176.09M | ▼ 81.08M | ▼ 75.24M | ▼ | |
Interest Income | 33.00K | ▼ 22.00K | ▲ 1.14M | ▼ 0.00 | 0.00 | ||
Interest Expense | 648.00K | ▲ 707.00K | ▲ 803.00K | ▲ 978.00K | ▼ 597.00K | ▼ | |
Depreciation And Amortization | 3.59M | ▲ 5.80M | ▲ 245.32M | ▼ 6.69M | ▼ 5.65M | ▼ | |
Ebitda | -121.45M | ▲ -115.78M | ▲ -79.56M | ▲ -16.97M | ▲ -7.17M | ▼ | |
Ebitda Ratio | -1.90 | ▼ -2.00 | ▲ -1.30 | ▲ -0.30 | ▲ -0.11 | ▼ | |
Operating Income | -125.05M | ▲ -115.78M | ▼ -324.88M | ▲ -23.66M | ▲ -12.82M | ▼ | |
Operating Income Ratio | -1.96 | ▼ -2.00 | ▼ -5.30 | ▲ -0.41 | ▲ -0.21 | ▼ | |
Total Other Income Expenses Net | -23.00K | ▲ 75.60M | ▼ 16.21M | ▼ -2.53M | ▼ -7.50M | ▼ | |
Income Before Tax | -125.68M | ▲ -40.19M | ▼ -308.67M | ▲ -26.18M | ▲ -20.32M | ▼ | |
Income Before Tax Ratio | -1.97 | ▲ -0.70 | ▼ -5.03 | ▲ -0.46 | ▲ -0.33 | ▼ | |
Income Tax Expense | 625.00K | ▲ 707.00K | ▼ 90.00K | ▼ -411.00K | ▲ -82.00K | ▼ | |
Net Income | -125.68M | ▲ -40.19M | ▼ -308.76M | ▲ -25.77M | ▲ -20.24M | ▼ | |
Net Income Ratio | -1.97 | ▲ -0.70 | ▼ -5.03 | ▲ -0.45 | ▲ -0.32 | ▼ | |
Eps | -0.52 | ▲ -0.17 | ▼ -26.23 | ▲ -0.99 | ▲ -0.78 | ▼ | |
Eps Diluted | -0.52 | ▲ -0.17 | ▼ -26.23 | ▲ -0.99 | ▲ -0.78 | ▼ | |
Weighted Average Shs Out | 240.19M | ▲ 241.49M | ▼ 11.77M | ▲ 25.98M | ▲ 26.06M | ▼ | |
Weighted Average Shs Out Dil | 240.19M | ▲ 241.49M | ▼ 11.77M | ▲ 25.98M | ▲ 26.06M | ▼ |